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Abstract 
Aim 
To develop clinical practice guidelines for nurse-administered procedural sedation 
and analgesia in the cardiac catheterisation laboratory. 
Background 
Numerous studies have reported that nurse-administered procedural sedation and 
analgesia is safe. However, the broad scope of existing guidelines for the 
administration and monitoring of patients who receive sedation during medical 
procedures without an anaesthetist presents means there is a lack of specific 
guidance regarding optimal nursing practices for the unique circumstances in which 
nurse-administered procedural sedation and analgesia is used in the cardiac 
catheterisation laboratory. 
Methods 
A sequential mixed methods design was utilised. Initial recommendations were 
produced from three studies conducted by the authors: an integrative review; a 
qualitative study; and a cross-sectional survey. The recommendations were revised 
in accordance with responses from a modified Delphi study. The first Delphi round 
was completed by nine senior cardiac catheterisation laboratory nurses. All but one 
of the draft recommendations met the pre-determined cut-off point for inclusion. 
There were a total of 59 responses to the second round. Consensus was reached on 
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all recommendations. 
Implications for nursing 
The guidelines that were derived from the Delphi study offer twenty four 
recommendations within six domains of nursing practice: Pre-procedural 
assessment; Pre-procedural patient and family education; Pre-procedural patient 
comfort; Intra-procedural patient comfort; Intra-procedural patient assessment and 
monitoring; and Post-procedural patient assessment and monitoring.  
Conclusion 
These guidelines provide an important foundation towards the delivery of safe, 
consistent and evidence-based nursing care for the many patients who receive 
sedation in the cardiac catheterisation laboratory setting.
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Summary Statement 
Why is this research needed? 
• Nurses in the cardiac catheterisation laboratory are required to administer and 
monitor procedural sedation and analgesia in complex circumstances, often 
without an anaesthetist present. 
• Nurses’ decisions regarding the management of sedated patients have an impact 
on clinical outcomes. It is therefore important they have access to professional 
guidelines to support their clinical practice and decision-making. 
• Clinical practice guidelines for procedural sedation and analgesia administered by 
nurses in the cardiac catheterisation laboratory setting will help to translate best 
evidence into practice.  
What are the key findings? 
• Recommendations for nursing practices associated with the administration and 
monitoring of procedural sedation and analgesia in the cardiac catheterisation 
laboratory setting are presented, together with a summary of the evidence to 
support these recommendations. 
• A total of 24 recommendations for nursing practice, spanning pre, intra and post-
procedural periods, were produced. 
• There is a paucity of high-level evidence to inform nurses’ clinical decision-
making in this field. 
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How should the findings be used to influence 
policy/practice/research/education? 
• These guidelines should be used to inform local hospital policy in support of 
nurse-administered procedural sedation and analgesia practice cardiac 
catheterisation laboratories. 
• These guidelines should be used as a foundation for professional bodies to set 
standards for practice, competency, education and training. 
• Further research should be conducted to strengthen justification for the 
recommendations derived from consensus and low-level evidence.  
Keywords 
Conscious sedation, Deep sedation, Heart catheterization, Artificial cardiac pacing, 
Cardiac electrophysiology, Nursing, Guidelines, Evidence-based practice. 
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Introduction  
In the absence of an anaesthetist, nurses usually take responsibility for the 
administration and monitoring of PSA in the CCL (Conway et al. 2013b, Conway et al. 
2012). Minimal, moderate or deep sedation may be used according to procedural 
requirements, cardiologists’ preferences and patient characteristics including their 
co-morbidities, level of pain and anxiety, and their sensitivity to sedative 
medications (Kezerashvili et al. 2008, Natale et al. 1996). Numerous studies have 
reported that nurse-administered procedural sedation and analgesia (PSA) is safe in 
the cardiac catheterisation laboratory (CCL) setting. Our recent integrative review of 
nurse-administered PSA in the CCL found that the authors of each included study 
reported this practice was safe due to the low incidence of reversible 
cardiopulmonary complications, which ranged from 2.4-9.4% (Conway et al. 2011). 
Of note, in the largest individual study conducted to date, only five deaths were 
observed in the roughly 10,000 patients studied (0.05%) (Kezerashvili et al. 2008). 
Importantly, the authors of this study reported that it was unclear whether the 
deaths were related to the administration of sedation (Kezerashvili et al. 2008). 
As a result of the safety data that have been reported, this practice is now common 
around the world, including in Australia and New Zealand (Gaitan et al. 2011, 
Trentman et al. 2009, ANZCA 2010, Conway et al. 2013c, Conway et al. 2013b, 
Conway et al. 2012). Morevover, it is anticipated that nurse-administered PSA 
practice in the CCL will not only continue but will likely even expand in scope as more 
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minimally invasive procedures become available with the rapid advances in 
technology that characterises contemporary cardiology practice.  
It is important to note, though, that nurses’ decisions and actions regarding the 
management of sedated patients have an impact on clinical outcomes (Odom-Forren 
2005). For example, unrecognised sedation-induced hypoventilation can lead to 
hypoxic episodes (Burton et al. 2006, Conway et al. 2013a). Thus, it is important 
nurses have access to evidence-based and professionally endorsed guidelines to 
assist their clinical decision-making.  
Anaesthetic professional organizations, such as the American Society of 
Anesthesiology and the Australian and New Zealand College of Anaesthestists, have 
produced guidelines to assist implementation of institutional policies and procedures 
for PSA that is administered without an anaesthetist present. In Australia and New 
Zealand specifically, the Australia and New Zealand College of Anaesthetists’ 
guidelines provide recommendations for the type of patients and the sedative and 
analgesic medications that are suitable, as well as training standards for non-
anaesthetist medical practitioners, staffing and patient monitoring requirements for 
PSA (ANZCA 2010). While these guidelines have been developed using robust 
methods and are informed by experts’ opinions, unfortunately, their broad scope 
has resulted in a lack of specific guidance regarding optimal nursing practices for the 
unique circumstances in which nurse-administered PSA is currently being used in the 
CCL. For example, while guidelines developed by the anaesthetics professional 
organisation recommend that an anaesthetist should be present if deep sedation is 
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to be used, in many CCLs around the world, deep sedation is administered by nurses 
(Conway et al. 2013c, Gaitan et al. 2011).  
Due to the non-specific nature of current guidelines, this study was designed to 
supplement existing guidelines by developing evidence-based recommendations for 
the unique circumstances in which nurse-administered PSA is currently being used in 
the CCL. Moreover, by producing an easy-to-use reference of the evidence-base 
supporting the recommendations, the guidelines aim to help nurses to make 
informed choices when caring for patients who are sedated in the CCL. The 
recommendations for nursing practice presented in this article have been endorsed 
by the Australia and New Zealand Interventional Nurses’ Council. 
Methods 
This study was informed by the National Health and Medical Research Council 
principles for the development of clinical practice guidelines (NHMRC 1998). A 
sequential mixed methods design (Creswell and Plano Clark 2007), comprising two 
phases, was used to develop guidelines for nurse-administered PSA in the CCL. 
Figure 1 illustrates the process used.  
The aims of Phase One were:  1) to appraise the current evidence available to inform 
nursing practices associated with the administration and monitoring of patients who 
receive PSA in the CCL setting; 2) to explore CCL nurses’ perceptions of the issues 
and challenges associated with nurse-administered PSA in the CCL; and 3) to 
characterise current nurse-administered PSA practices across Australian and New 
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Zealand CCLs. Phase One commenced with an integrative review of research 
regarding nurse-administered PSA in the CCL and other clinical areas, including 
review of relevant clinical practice guidelines (Conway et al. 2011). This was the first 
review to systematically appraise the available evidence supporting the use of nurse-
administered PSA in the CCL. A major finding was that, overall, nurse-administered 
PSA in the CCL was generally deemed to be safe. However, it was concluded from 
the analysis of the studies that were included in the review, that the management of 
sedation in the CCL was impacted by a variety of contextual factors including local 
hospital policy, workforce constraints and cardiologists’ preferences for the type of 
sedation used. 
The second study in Phase One was a qualitative study. Its aim was to explore the 
issues and challenges associated with nurse-administered PSA in the CCL. A total of 
23 nurses from 16 CCLs across four Australian states and New Zealand participated in 
the study. While the results of the qualitative study are reported elsewhere (Conway 
et al. 2013b), in brief, major themes emerged from analysis of the qualitative data 
regarding the lack of access to anaesthetists, the limitations of sedative medications, 
the barriers to effective patient monitoring and the impact that the increasing 
complexity of procedures has on patients' sedation requirements. 
The final component of the Phase One was a practice survey, which was conducted 
to characterise current nurse-administered PSA practice in Australian and New 
Zealand CCLs (Conway et al. 2013c). Of the estimated total number of CCLs in 
Australia and New Zealand, 54% responded to the survey. While nurse-administered 
PSA was reported to be used in nearly all the CCLs surveyed (n = 58; 94%), sedation-
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monitoring practices varied considerably between institutions. The most common 
medications used for nurse-administered PSA were benzodiazepines, opioids or a 
combination of both. Deep sedation was purposefully induced during nurse-
administered PSA in 20% (n = 12) of respondents practice settings. 
Based on the findings from the exploratory phase, a draft set of guideline 
recommendations was developed by the research team. This paper presents results 
of the final phase, consisting of a modified Delphi study, which was conducted to 
refine the draft set of guidelines by consensus of practicing CCL nurses’ opinions. 
Design 
A modified Delphi study was conducted. The Delphi technique is recognised as a 
valid and reliable method to achieve consensus (Powell 2003). As participants were 
asked for their reactions regarding previously prepared information derived from 
Phase One of this project, the particular ‘modification’ of the Delphi technique used 
in this study is known as ‘reactive’ (McKenna 1994). Ethical approval was received 
from a university human research ethics committee (HREC Register Number V2011 
46). All data were collected anonymously. Participation was voluntary and 
participants were free to withdraw from the study at any time. 
Procedure 
As is recommended for a Delphi study, an expert panel was recruited for the first 
round (Hasson et al. 2000). An invitation to participate in the expert panel was sent 
by email to known contacts from the chair of the Australia and New Zealand 
Interventional Nurses’ Council. The inclusion criteria were that participants were 
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currently employed within the CCL setting in a senior clinical role or with clinical 
experience in the CCL setting of three or more years and had an interest in PSA in the 
CCL. Nine nurses agreed to participate in the panel. Two participants practised in 
New South Wales, two in South Australia, three in Western Australia and two in New 
Zealand. This was considered to be an adequate panel size as previous research has 
indicated that views of a small group with expert knowledge can be representative 
of a target population (Vella et al. 2000).  
In round one, a survey was distributed to the expert panel, which consisted of six 
items for each of the recommendations as well as free text space for suggestions 
about wording, content and missing recommendations (see Table 1). The items 
requested panel members to rate their agreement on a 10-point scale.  A 10 point 
scale with descriptors at each end was chosen for this study because these types of 
scales have demonstrated acceptable validity and reliability (Pettersen et al. 2004). A 
hierarchy, which was used in a previous cardiovascular nursing clinical practice 
guideline development process, was used to grade each recommendation (Rolley et 
al. 2011). Practices supported by high-level research evidence were accorded the 
strongest recommendation, while those without research evidence were graded 
according to the level of consensus reached (see Table 2). Recommendations in the 
draft of the guidelines were refined through descriptive analysis of the survey data. 
Twenty seven recommendations were submitted to the expert panel for evaluation 
in round one. Only one of the recommendations scored below the median cut-off 
score of 7.5 to indicate consensus. For this reason, the recommendation was 
excluded from the revised set of guidelines. This recommendation related to the 
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need for research into medications other than midazolam and fentanyl for nurse-
administered PSA in the CCL (median = 7; IQR = 2). In light of suggestions from the 
consensus panel, two further recommendations were removed by combining their 
content with two related recommendations and minor changes were made to the 
wording of other recommendations in order to increase clarity. Thus, there were 24 
recommendations in the revised set of guidelines that were sent for consideration by 
the consensus panel in round two. 
Following development of a revised set of guidelines, a broader sample of CCL nurses 
(consensus panel) was sought to determine the degree of consensus on the 
recommendations. Only small improvements in reliability were expected from 
recruiting a larger sample size for the second round of the Delphi study (Ayanian et 
al. 1998). Yet, it was highly relevant in this study to try to maximise the potential for 
the guidelines to be representative of the views of practising CCL nurses because, 
due to limited research evidence, many of the recommendations needed to be made 
by consensus rather than from patient outcome data. An invitation to participate in a 
consensus panel was sent by email to known contacts of the chairperson of the 
Australia and New Zealand Interventional Nurses’ Council. In addition, a snowball 
sampling method was utilised in order to increase the number of participants 
(Wright and Stein 2005). The inclusion criteria were that participating nurses were 
currently registered and practising in a CCL. Fifty nine nurses agreed to participate. In 
this round, a survey similar to that used in round one, containing 24 
recommendations, was distributed to the consensus panel. Again, a 10-point scale 
was used to rate agreement. A 100% response-rate (n = 59) was achieved in round 
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two. Over half of the consensus panel (54%) were Registered Nurses employed in 
senior CCL positions such as Clinical Nurse, Clinical Nurse Specialist, Clinical Coach, 
Nurse Co-ordinator or Nurse Manager. Participants were from South Australia (n=13, 
22%), Western Australia (n=13, 22%), Queensland (n=10, 17%), Victoria (n=11, 19%), 
New South Wales (n=1, 2%), Tasmania (n=2, 3%) and New Zealand (n=9, 15%). All 24 
of the recommendations reached the pre-determined cut-off point for consensus 
(median > 7.5). 
Implications for nursing practice 
 The final recommendations for nursing practice, presented in Table 3, were 
categorised into six domains including pre-procedural assessment, pre-procedural 
patient and family and education, pre-procedural patient comfort, intra-procedural 
patient comfort, intra-procedural patient monitoring and post-procedural patient 
monitoring.  
Domain 1: Pre-procedural assessment 
Suitability for nurse-administered PSA 
Some medical conditions have been shown to increase the risk of PSA-related 
complications (Taylor et al. 2011, Qadeer et al. 2009). Therefore, appropriate patient 
selection is vital for ensuring a safe PSA encounter. Moreover, it was noted by 
participants in phase one that it was important for processes to be in place to ensure 
that patients who may not be suitable for nurse-administered PSA are identified at a 
time that will ensure the procedure does not have to be delayed in order to arrange 
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anaesthetic support. As such, it is recommended that the cardiologist should be 
alerted and the suitability of nurse-administered PSA considered if patients exhibit 
risk factors for increased risk of PSA-related complications. 
Recovery 
In the qualitative study, it was identified that nurses perceived patients who received 
large doses of sedative and analgesic medications during long electrophysiology-
based procedures required longer periods of close observation in the recovery area 
(Conway et al. 2013b). This finding is not supported by patient outcome data. As 
such, further research is required. Nonetheless, it is recommended by consensus 
that, in order to ensure adequate staffing is available, the potential for extended 
duration of sedation recovery should be considered. 
Risk of complications 
Recent evidence indicates that patient with acute illness are more likely to 
experience impaired respiratory function during nurse-administered PSA (Conway et 
al. 2013a). Also, the induction of deep sedation is associated with higher rates of 
PSA-related respiratory complications compared with moderate sedation (Conway et 
al. 2011). Therefore, it is recommended that risk of impaired respiratory function 
should be considered so that intensive respiratory monitoring, such as the use of 
capnography, can be selectively applied.  
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Risk of increased pain and discomfort 
High levels of pre-procedural anxiety and pre-existing musculoskeletal injuries 
contribute to increased pain and discomfort during procedures (Beddoes et al. 2008, 
Gallagher et al. 2010). Therefore, consideration of these conditions is recommended 
to be part of pre-procedural assessment. 
Domain 2: Pre-procedural patient and family education 
Previous guidelines have recommended that patients should be provided with 
information about the risks of sedation and preparation requirements (Gross et al. 
2002, ANZCA 2010). However, a major challenge associated with nurse-administered 
PSA in the CCL that was noted by nurses in the qualitative study, was the difficulty in 
managing patients who experienced a greater degree of pain or discomfort than 
they anticipated (Conway et al. 2013b). Therefore, it was recommended by 
consensus that information about the anticipated degree of pain and discomfort 
during the procedure should also be provided. Integrating this patient education into 
existing pre-procedural information that is already routinely provided would be the 
most optimal method of delivering this education (Astley et al. 2008). 
Domain 3: Pre-procedural patient comfort 
In the most recent and largest randomised controlled trial, patients who received 
premedication for cardiac catheterisation were not, as anticipated, less anxious than 
the control group (Woodhead et al. 2007). As there is limited evidence for 
administration of oral benzodiazepines to reduce anxiety, it is recommended pre-
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medication is used on a patient-specific basis only. 
Domain 4: Intra-procedural patient comfort 
Medications for PSA 
Serious adverse events associated with the administration of midazolam and 
fentanyl for nurse-administered PSA in the CCL are rare (Kezerashvili et al. 2008). As 
such, a combination of midazolam and fentanyl is recommended to be used for 
nurse-administered PSA in the CCL. It is important to note though, that other 
sedative and analgesic agents, such as propofol, dexmedetomidine, ketamine, and 
remifentanil have several desirable properties including a rapid onset of action and 
short half-life (Hayman et al. 2012, Behan et al. 2008, Mandel et al. 2011). Also, 
evidence demonstrating their safety is emerging (Kottkamp et al. 2011, Sayfo et al. 
2012, Salukhe et al. 2012, Tang et al. 2007, Wutzler et al. 2012). However, more 
evidence is required in order to explicate the type of patients that are suitable, the 
degree of patient monitoring that is required and specific education, training and 
accreditation requirements (de Bono 2012, Hummel and Awad 2011). Therefore, the 
use of these agents for nurse-administered sedation in the CCL is not recommended 
for clinical practice.  
Non-pharmacological stress reducing therapies 
Investigations into the use of non-pharmacological stress reducing therapies, such as 
music therapy and visualisation, have found these interventions were simple to 
apply in practice, did not disrupt procedures and induced relaxation during cardiac 
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procedures (Nilsson et al. 2009, Salmore and Nelson 2000, Norgaard et al. 2013). 
Therefore, it is recommended these therapies should be offered to patients. 
Domain 5: Intra-procedural patient assessment and monitoring 
Supplemental oxygen 
It is widely recognised, and already recommended in previous clinical guidelines for 
PSA without an anaesthetist, that supplemental oxygen should be used because it 
reduces the occurrence of hypoxia secondary to respiratory depression (Rozario et 
al. 2008, ANZCA 2010, Deitch et al. 2008). Therefore, it is recommended that nurses 
apply supplemental oxygen to all patients who receive nurse-administered PSA in 
the CCL. 
Pulmonary ventilation and oxygenation 
Sedative and analgesic medications can depress respiratory drive, resulting in 
reduced tidal volume, reduced respiratory rate and periods of apnoea (Malamed 
2003). Also, a common side effect of PSA is relaxation and consequent displacement 
of the pharyngeal musculature leading to partial obstruction of the airway (Odom-
Forren and Watson 2005). These side effects can lead to inadequate ventilation and 
oxygenation if corrective interventions are not applied promptly. Therefore, it is 
recommended that nurses continuously monitor pulmonary ventilation and 
oxygenation of sedated patients with pulse oximetry and clinical observation of 
respiration. In addition, capnography should be used to monitor patients who are 
more likely to experience respiratory depression. Such patients include those 
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undergoing defibrillation threshold testing, cardioversion, long electrophysiology-
based procedures and also those receiving continuous infusions of sedative and 
analgesic medications (Waugh et al. 2011). 
Cardiovascular function 
It is recommended that nurses utilise an ECG to monitor heart rate and rhythm and 
either invasive or non-invasive blood pressure monitoring during PSA (ANZCA 2010, 
Gross et al. 2002). Furthermore, while impaired cardiovascular function related to 
nurse-administered PSA in the CCL is rare, evidence suggests corrective interventions 
such as intravenous fluid bolus and administration of sedation reversal medications 
are effective treatments (Geiger et al. 1997, Fox et al. 2007, Natale et al. 1996, 
Pachulski et al. 2001). As such, it is recommended that nurses promptly report to the 
proceduralist any indication of compromise in cardiac function. 
Goal of procedural sedation and analgesia 
In order to facilitate optimal titration of PSA, it is recommended that nurses report 
any signs of pain, discomfort, anxiety and agitation as well as any unintended 
depression in level of consciousness to the proceduralist. It is further recommended 
that sedation scales can be used for standardised monitoring of consciousness 
during sedation over time (Conway et al. In press). 
Monitoring during deep sedation 
While moderate sedation is targeted for the majority of procedures, a transient 
increase in the level of sedation is required for defibrillation threshold testing 
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(DTT) and cardioversion, as these are particularly painful and distressing aspects of 
procedures (Timperley et al. 2008). In the survey of nurse-administered PSA practice 
in Australian and New Zealand CCLs that was conducted as part of this project, it was 
identified that 20% of CCLs do utilise nurse-administered PSA for defibrillation 
threshold testing and cardioversion (Conway et al. 2013c). Also, previous research 
has demonstrated the safety of nurse-administered PSA for DTT and cardioversion 
(Natale et al. 1996, Manolis et al. 2000, Fox et al. 2007, Lipscomb et al. 1998, 
Kezerashvili et al. 2008, Sayfo et al. 2012). As such, it is recommended nurse-
administered PSA can be used. However, as there is a more pronounced impact on 
respiratory physiology at the level of deep sedation, it is recommended that 
capnography should be used (Waugh et al. 2011). In addition, nurses should increase 
the frequency of their assessment and documentation of the adequacy of cardiac 
and respiratory function. Any indication of compromise in respiratory or cardiac 
function should be promptly reported to the proceduralist and corrective 
interventions implemented immediately. 
Staffing 
Nurse staffing for procedures differs between CCLs (Conway et al. 2013c). 
Furthermore, in the previous phases of this project, it was identified that nurses 
generally deemed that one scout nurse was suitable for diagnostic and 
interventional coronary and vascular procedures, yet they noted that excluding a 
sedated patient from their direct vision in order to gather equipment was not 
optimal during electrophysiology-based procedures. The reason noted was that 
usually higher doses of PSA medications were used (Conway et al. 2013b). It is 
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important to note that research has not yet been undertaken to compare the 
effectiveness of different staffing ratios for nurse-administered PSA in the CCL on 
either patient outcomes, or on costs. As such, further research is required. 
Nonetheless, it was recommended by consensus that if nurses-administered PSA is 
to be used for an electrophysiology-based procedure, two scout nurses should be 
allocated. 
Anaesthetic service support 
In phase one, it was identified that, due to the unpredictable nature of the effects of 
PSA on cardiac and respiratory function, situations arise where the patient requires 
more specialised care than can be supplied by a registered nurse (Conway et al. 
2013b). This finding is supported by a study of PSA during electrophysiology-based 
procedures, where the investigators found that PSA needed to be converted to a 
general anaesthetic in 11% of cases (Trentman et al. 2009). Therefore, it is 
recommended by consensus that each institution should establish a system that 
facilitates access to support from an anaesthetic service for situations that the nurse 
deems the patient’s needs regarding the administration or monitoring of PSA fall 
outside their scope of practice, even if this means the procedure must be delayed or 
abandoned. 
Domain 6: Post-procedural patient assessment and monitoring 
To prevent post-procedural complications related to PSA, patients require close, 
specialised monitoring by a nurse either in the procedural area, or in another 
appropriately staffed recovery unit, for a period of time after the procedure has 
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finished (Gross et al. 2002, ANZCA 2010). It is recommended that patients remain 
monitored until they are oriented, are able to move all limbs on command, are able 
to maintain a normal oxygen saturation level without oxygen supplementation and 
also until their vital signs have returned to baseline level (Gross et al. 2002, ANZCA 
2010). A standardised approach to determining suitability for discharge from the 
recovery area can be achieved with the use of a validated sedation recovery score 
(Aldrete and Kroulik 1970).  
Conclusion 
These guidelines provide an important foundation towards the delivery of safe, 
consistent and evidence-based nursing care for the many patients who receive 
sedation in the cardiac catheterisation laboratory setting. The guidelines were 
developed from evidence in the literature and practising clinicians’ opinions, which is 
the process typically used to develop guidelines in healthcare (NHMRC 1998, 
Shekelle et al. 1999). To ensure our recommendations were applicable to current 
clinical practice, we thoroughly reviewed existing literature, and then gathered 
robust data using several methods: a qualitative study, a quantitative survey of 
practice, and a modified Delphi study. As such, these guidelines provide important 
information for CCL nurses to consider in their provision of patient care. Similarly, 
the recommendations provide highly relevant information for institutions to 
consider regarding their facilities, equipment and the support that they should make 
available for nurses.  
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Of note, recommendations based on consensus should be interpreted with caution 
(Tricoci et al. 2009) and the clinical usefulness of guidelines should be evaluated 
(Grimshaw et al. 1995); this has yet to be done. Implementation projects are planned 
to determine the effectiveness of the guidelines in improving patient and health 
service outcomes. A further limitation of our guidelines is that only CCL nurses were 
participants in all studies that informed their development. Yet, they could be used 
as a foundation for national professional bodies that represent the nurses, 
cardiologists and anaesthetists that work in CCLs to conduct more extensive multi-
disciplinary consultation and set standards for PSA practice, resource requirements, 
competency, education and training. 
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Table 1 Recommendation Assessment Items 
Item Response Type 
I agree with this recommendation 10-point scale 
I agree with the grade of this recommendation 10-point scale 
I agree with the level of evidence for this 
recommendation 
10-point scale 
This recommendation is relevant to interventional 
cardiovascular nursing practice 
10-point scale 
Is this recommendation already adopted within your 
practice setting? 
Yes/No 
This recommendation could easily be adopted within 
my practice setting  
10-point scale 
If you disagree with the wording of this 
recommendation, please provide an alternative. 
Free text 
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Table 2 Grading system for evidence and recommendations (Rolley et al. 2011) 
Level of 
evidence 
Study design Grade of 
recommendation  
Description 
I Evidence obtained from 
a systematic review of all 
relevant randomised 
controlled trials.  
A Body of evidence can be 
trusted to guide 
practice.  
II Evidence obtained from 
at least one properly 
designed randomised 
controlled trial.  
B Body of evidence can be 
trusted to guide practice 
in most circumstances.  
III-1 Evidence obtained from 
well-designed pseudo-
randomised controlled 
trials (alternate 
allocation or some other 
method).  
C Body of evidence 
provides some support 
for recommendations 
but care should be taken 
in application.  
III-2 Evidence obtained from 
comparative studies with 
concurrent controls and 
allocation not 
randomised (cohort 
studies), case—control 
studies, or interrupted 
time series with a 
control group.  
D Evidence is weak and 
recommendation should 
be applied with caution. 
Consensus based on 
expert opinion only.  
III-3 Evidence obtained from 
comparative studies with 
historical control, two or 
more single-arm studies, 
or interrupted time 
series without a parallel 
control group.  
  
IV Evidence obtained from 
case series, either post-
test or pre-test and post-
test.  
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Table 3 Summary of guideline statements 
Recommendation  
 
Median 
score 
Grade of 
recommendation 
Level of 
Evidence 
 
Domain 1: Pre-procedural assessment 
 
For patients scheduled to receive deep sedation without an anaesthetist present 
(electrophysiology procedures during which continuous infusions of sedative or analgesic 
medications are to be administered, DTT or cardioversion) 
Alert the Cardiologist if: 
• BMI > 35 
• Prior difficulty with sedation/anaesthesia 
• Substance abuse 
• Expected length of procedure > 6 hours 
• Sleep apnoea, undiagnosed but high-risk for sleep apnoea (assessed using Berlin 
questionnaire) or obesity hypoventilation syndrome (assessed using serum venous 
bicarbonate) 
• Significant respiratory disease, SpO2 < 94% on room air 
• Significant renal/hepatic impairment 
• Low ejection fraction 
9 D - 
Consider the potential for extended duration of sedation recovery in order to facilitate 
adequate post-procedural staffing ratios. 
8 D - 
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Consider risk factors of impaired respiratory function in order to tailor appropriate strategies 
for intensive respiratory monitoring. 
• Emergency admission 
• Transfer from a critical care unit (intensive care unit, coronary care unit, emergency 
department) 
• On haemodynamic support in lead up to the procedure (temporary pacing, inotropes, 
anti-arrhythmics, vasodilators) 
• On respiratory support in lead up to the procedure (supplemental oxygen) 
• Potential requirement for deep sedation during defibrillation threshold testing or 
cardioversion  
8 C III-2 
Consider risk factors of increased pain and discomfort 
• Previous muscloskeletal injuries  
• High levels of anxiety (Faces Anxiety Scale is a simple tool that can be used to identify 
high levels of anxiety) 
8 C 
 
 
 
IV 
 
Domain 2: Pre-procedural patient and family education 
 
Information should be made available to patients and their families, which clearly outlines the 
proposed method of sedation and analgesia. If the proposed method is nurse-administered 
procedural sedation and analgesia rather than a general anaesthetic, a clear description of the 
anticipated degree of pain and discomfort associated with the procedure should be provided 
and consent signifying the patient’s understanding and willingness to undergo the procedure 
with this mode of sedation. 
8 D - 
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Domain 3: Pre-procedural patient comfort 
 
The use of pre-procedural sedation with oral medications should be administered on a patient-
specific basis only . 
9 B II 
 
Domain 4: Intra-procedural patient comfort 
 
The proceduralist may prescribe a combination of benzodiazepines and opioids for a registered 
nurse to administer intravenously, either pre-emptively for procedures known to induce a 
considerable degree of pain and discomfort, or in response to either patient self-report, or 
clinical signs of anxiety, pain and discomfort associated with the procedure. 
The proceduralist must be present when sedation is administered by the registered nurse. 
10 B IV 
Other sedative and analgesic agents, such as propofol, dexmedetomidine, ketamine and 
remifentanil, have several desirable properties over the opioid and benzodiazepine 
combination that is most commonly used for PSA including rapid onset of action and short half-
life. Also, evidence demonstrating their safety is emerging. However, more evidence is required 
in order to explicate the type of patients that are suitable, the degree of patient monitoring that 
is required and specific education, training and accreditation requirements. Therefore, the use 
of these agents for nurse-administered sedation in the CCL is not recommended. 
10 C IV 
Non-pharmacological stress reducing therapies, such as music and visualisation, should be 
offered for patients who choose to utilise this relaxation technique to reduce anxiety during 
procedures in the CCL. 
8 B II 
Domain 5: Intra-procedural patient assessment and monitoring  
Administer supplemental oxygen to patients who receive intravenous sedative and analgesic 9 B II 
 33 
medications. 
If sedation and analgesia is administered, nurses should continuously monitor pulmonary 
ventilation and oxygenation using pulse oximetry combined with clinical observation of 
respiration in order to detect potential complications including: 
-Hypopnoeic hyopventilation (reduced tidal volume) 
-Bradypnoea (reduced respiratory rate) 
-Apnoea (absence of respiration) 
-Partial airway obstruction 
Adequacy of ventilation and oxygenation should be recorded before and after sedative and 
analgesic titration and at least every 10 minutes by documenting the oxygen saturation value 
and respiratory rate. Any indication of respiratory compromise needs to be promptly reported 
to the proceduralist and corrective interventions implemented immediately.  
Corrective interventions for impaired respiratory function may include repeated physical 
stimulation, airway realignment or placement of airway adjuncts, increasing supplemental 
oxygen or administration of sedation-reversal medications. 
10 D IV 
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Capnography should be used in addition to pulse oximetry and clinical observation of 
respiration for all patients at higher risk of impaired respiratory function during procedural 
sedation and analgesia. Risk factors for impaired respiratory function include: 
1. Deep sedation for cardioversion or defibrillation threshold testing.  
2. Electrophysiology procedures with prolonged duration. 
3. For any procedures during which continuous infusions of sedative or analgesic medications 
are administered 
Adequacy of ventilation and oxygenation when capnography is being used should be recorded 
by documenting the oxygen saturation value, respiratory rate, characteristics of the 
capnographic waveform and end-tidal carbon dioxide value. 
8 D - 
Nurses should monitor cardiovascular function using invasive or non-invasive blood pressure 
measurement and an ECG to monitor heart rate and rhythm in order to detect potential 
complications related to sedation including hypotension and bradycardia. 
Any indication of compromise in cardiac function needs to be promptly reported to the 
proceduralist and corrective interventions implemented immediately. Corrective interventions 
for impaired cardiac function related to sedation may include intravenous fluid bolus or 
administration of sedation-reversal medications. 
Adequacy of cardiovascular function should be recorded before and after sedative and 
analgesic titration and at least every 10 minutes by documenting the blood pressure, heart rate 
and heart rhythm. 
9 D IV 
The goal for nurse-administered procedural sedation and analgesia in the CCL should be for the 
patient to retain the ability to respond to verbal stimulation and maintain normal 
cardiopulmonary function while providing as much comfort as possible. 
9 D IV 
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Nurses should report any signs of pain, discomfort, anxiety and agitation to the proceduralist in 
order to facilitate titration of sedation and analgesia.  
While patients can self-report feelings of distress, nurses should also monitor for clinical signs of 
pain, discomfort, anxiety and agitation, as well as the effectiveness of sedation and analgesia in 
reducing or alleviating these distressing experiences. 
Clinical signs of pain/discomfort/anxiety include: 
-Increasing heart rate and blood pressure 
-Frequent readjustment of body position 
-Facial grimacing 
-Groaning 
Clinical signs of agitation include: 
-Uncontrolled leg movements 
-Reaching for groin or oxygen mask  
10 D - 
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Nurses should regularly monitor level of consciousness during procedural sedation and 
analgesia. The level of consciousness should be documented before and after sedative and 
analgesic titration as well as at least every 10 minutes. 
Consciousness should be assessed by determining the degree of stimulation required to elicit a 
PURPOSEFUL response.  The stimulation should begin as verbal, then progress to increasing 
levels of physical stimulation. 
Careful attention should be focused on distinguishing reflex withdrawal from a ‘purposeful’ 
response to stimulation, such as the ability to follow simple commands (e.g. establishing eye 
contact or responding with comprehensible words).  
If there is an unintended further depression in the level of consciousness, such that the patient 
does not respond to verbal stimulation, nurses should first implement a simple corrective 
intervention, such as repeated physical stimulation. Also, it is essential that the depressed level 
of consciousness is reported to the proceduralist so that further doses of sedative and analgesic 
medications can be withheld or infusions of sedative medications can be discontinued until 
such a time that the patient responds purposefully to verbal stimulation.  
In the case that the patient remains unresponsive to verbal stimulation, airway adjuncts can be 
used in order to protect the patient's airway and administration of sedation reversal 
medications may also be required. 
9 D IV 
Scales can be used to assess level of consciousness during sedation (Observer's assessment of 
alertness/sedation OAA/S). 
9 D - 
At the cardiologist's discretion, a purposeful increase in the level of sedation, to the point that 
the patient does not respond to verbal stimulation, may be used to facilitate defibrillation 
threshold testing and cardioversion. 
8 C IV 
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In the case that nurse-administered procedural sedation and analgesia is used for defibrillation 
threshold testing or cardioversion, nurses should use capnography to monitor ventilation and 
increase the frequency of their assessment and documentation of the adequacy of cardiac and 
respiratory function (refer to Domain Four - Recommendations 1-3). Any indication that cardiac 
or respiratory compromise has occurred should be promptly reported to the proceduralist and 
corrective interventions implemented immediately.   
After defibrillation threshold testing or cardioversion, level of consciousness and adequacy of 
cardiac and respiratory function needs to be monitored continuously until the patient is 
responsive to verbal stimulation. If the patient remains unresponsive to verbal stimulation, 
nurses should first implement a simple corrective intervention, such as repeated physical 
stimulation. Also, it is essential that the prolonged depressed level of consciousness is reported 
to the proceduralist so that further doses of sedative and analgesic medications can be 
withheld or infusions of sedative medications can be discontinued until such a time that the 
patient responds purposefully to verbal stimulation.  
In the case that the patient remains unresponsive to verbal stimulation, airway adjuncts can be 
used in order to protect the patient's airway and administration of sedation-reversal 
medications may be required. 
8 D - 
For diagnostic and interventional coronary and vascular procedures, the registered nurse can be 
responsible for duties other than sedation administration and monitoring provided there is 
another registered nurse or cardiac technician/physiologist allocated to the procedure who is 
performing the advanced cardiac monitoring role. 
8 D - 
 38 
For electrophysiology procedures (including pacing, ICD, CRT, EPS, Ablation), renal denervation 
procedures and structural heart procedures during which nurse-administered procedural 
sedation and analgesia is intended to be used, two registered nurses need to be allocated to 
the case. The primary duty of at least one of the registered nurses is to administer and monitor 
sedation and implement any interventions required to support or restore respiratory or cardiac 
function, while the other can be responsible for other duties. 
8 D - 
Systems should be in place so that if at any time before or during the procedure the nurse 
considers the patient’s procedural sedation and analgesia requirements to fall outside of their 
scope of practice, support from an anaesthetist must be arranged, even if this means the 
procedure must be delayed or abandoned. 
10 D - 
Domain 6: Post-procedural patient assessment and monitoring  
Patients who receive nurse-administered procedural sedation and analgesia are to remain in 
the procedural area or another clinical area where close, specialised monitoring of the patient’s 
sedation status can be provided until the patient is oriented, able to move all limbs on 
command, is able to maintain their oxygen saturations without oxygen supplementation and 
vital signs have either returned to baseline or are within acceptable limits. 
10 D - 
A validated standardised assessment tool, such as the Post Anaesthetic Recovery Score (PARS), 
should be used to document the patient's progress to recovery from sedation at regular 
intervals and prior to being discharged from the clinical area in which they are being recovered.  
9 C III-1 
* A proceduralist was defined as a physician, usually a specialist or subspecialist who performs diagnostic or therapeutic procedures. 
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